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A 12-year-old girl with homozygous 
type-11 hyperlipoproteinamia, which 
was refractory to medical treatment, had significant 
improvement in  her serum lipid abnormalities during 
a trial of parenteral hyperalirnentation. Subsequently, 
end-to-side portacaval shunt caused striking reduction 
of the serum-cholesterol and low-density (beta) lipo- 
protein elevations, regression or  disappearance of 
xanthomatous skin and tendinous lesions during the 
6f months since operation, and relief of severe cardiac 
symptoms apparently as  resorption occurred of 
xanthomatous deposits in the aortic valve and around 
the coronary arteries. Liver biopsy at  Sf months 
showed several changes, including depletion of rough 
endoplasmic reticulum; this finding was consistent 
with the possibility that the portal diversion caused 
the desired therapeutic effects by inhibiting synthesis 
of hepatic cholesterol or low-density lipoprotein. 
I N T R O D U C T I O N  
SYMPTOMATIC teenagers with homozygous type IIA 
hyperiipoproteinzrnia have little chance of achieving 
a normal lifespan or even of reaching middle age.' 
Mautafis et al.' and L e w  et  aL3 have reported re- 
duction of serum-choles*:rol in such patients after 
treatment with diet, cholestyramine, and nicotinic 
acid. However, the results were not predictable. An 
even less satisfactory experience has been recorded 
by o t h e n H  
We describe here the course of a 12-year-old girl 
with type IIA hyperlipoproteinzmia in whom a malor 
myocardial infarction and significant ac : stenosis 
presumably due to xanthoma d e p o s i t i ~  developed 
despite therapy with diet, cholestyramne, dexuo- 
thyroxine, clofibrate, and nicotinic acid. An end-to- 
side portacaval shunt was performed with prompt and 
sustained regression of the hyperlipidzmia and hyper- 
l i p o p r o t e i n d a ,  coupled with a remarkable sub- 
jective and objective clinical improvement over the 
ensuing 6f months. T h e  result il prompt us to 
recommend portal diversion for t er patients with 
this disease who prove to be refractory to conven- 
tional therapy. 
C A S E - R E P O R T  
A 12-year-old girl was f is t  noted at age 6 months 
to have multiple yellowish lesions over her hands and 
feet. At age 3 years tuberous and tendinous xanthomas 
were noted and her cholesterol levels were found to vary 
between 850 and 950 mg. per. 100 ml. Low-density 
(beta) lipoproteins were elevated and very-low density 
(pre-beta) lipoproteins were normal on electrophoresis. 
Triglyceride levels have always been normal. Three 
glucose-tolerance tests have been normal. Both parents 
and her only sibling were subsequently found to have 
elevated serum-cholesterol levels (father 350 mg. per 100 
ml., mother 347 mg. per 100 ml., and her 14-year-old 
sister 395 mg. per 100 ml.). Her mother had had myo- 
cardial infarction at age 3 1 years. 
Between the ages of 3 and 7 years the patient was 
treated with a low-far'diet, including a period of complete 
fat restriction in the hospital, with serum-cholesterol 
levels remaining above 600 mg. per 100 ml. In 1967, 
at age 7 years, she was given cholestyramine, 12 g. per 
day, and had a rise in the cholesterol level from 637 mg. 
per 100 ml. to 894 mg. per 100 ml. Prothrombin levels 
at that time f ~ '  from 100 to 70°6. Demothyroxine 
(' Choloxin ') 2 .:g. daily was also tried with no fall in 
the serum-cholestcrol. Clofibrate (' Atromid-S ') mat-  
ment (05-1.0 g. twice daily) was tried between 1968 
and 1972, at times in combination wlth nicotinic acid 
(200 mg. four times daily) or cholestyramine (' Questran ') 
(12-16 g. per day), with cholesterol levels remaining above 
600 mg. per 100 ml. In 1972, a trial of cholestyra- 
mine therapy (12-16 g. per day> in combination with 
TIME IN WEEKS 
Fig. l--Ch=cll in cholesterol and triglycerides durine intr8- 
venous hyperdimenration. 
nicotinic acid, 800 mg. per day, also resulted in no fall 
in serum-cholesterol levels. For 3 months in 1972 she 
was given a synthetic no-cholesterol diet (' Vivonex '), 
with cholesterol levels remaining in the 600-700 mg. per 
100 ml. range. 
Finally, in November, 1972, she was treated with 
intravenous hyperalimentation (2076 glucose, 3 76 
aminoacids, minerals, and vitamins) for 3 weeks with 
minimal oral intake. Cholesterol gradually declined dur- 
ing the intravenous therapy and levels were repeatedly 
below 600 mg. per 100 ml. for the first time in her life 
(fig. 1). A low of 390 mg. per 100 ml. was attained 2 
weeks after discontinuing the hyperalimentation, but 
levels soon rose again. Low-density-lipoprotein levels 
also fell during hyperalimentation, with pre-alimentation 
levels of 1019 and 1029 mg. per 100 ml., and a level 
of 322 mg. per 100 ml. 3 weeks after starting therapy. 
Triglyceride levels (fig. 1) are more difficult to evaluate 
since they were never elevated, but in comparison to 
the value of 97 mg. per 100 ml. just prior to treatment, 
or the mean of 9 fasting values of 95+ 18 (s.D.) mg. per 
100 ml. approximately a month later (see fig. 2), her 
levels during the intravenous hyperalimentation ( 6 0 t 8  
[s.D.] mg. per 100 ml.) were lower (p<OsO1). 
During the years of medical management, the xantho- 
matous lesions in the skin and elsewhere had continued 
to develop. At age 6 years, lipid masses were excised 
from the lower Achilles tendons, but these promptly re- 
turned. At age 7 years aortic stenosis was suspected 
DAYS MONTHS 
Fig. 2-Eaect of portal diversion on trirlyceride concentrmtions. 
The normal range m our laboratory for this age is 70-120 mg. 
p a  100 ml. The preoperanve value represents rhc mean of 
9 determinations tone standard deviauon. 
because of an aortic systolic murmur and was confirmed 
by cardiac catheterisation. The gradient across the aortic 
valve was 24 mm. Hg. In Novmbcr, 1972 (age 12 years, 
2 months), cardiac catheterisation, which was repeated 
because of dehi te  cardiac symptoms, showed that the 
gradient across the aortic valve had increased to 56 mm. 
Hg. On coronary arteriograms, the anterior descending 
and right coronary arteries showed generaiised narrowing 
and the circumflex artery could not be displayed. 
In December, 1972, the patient began to have pro- 
gressively more severe angina pectoris as well as con- 
gestive heart-failure which could no longer be controlled 
despite therapy with nitroglycerin, digitalis, hydrodiuril, 
and spironolactone. . In early February, 1973, she 
suffered acute anterior septal myocardial infarction. Be- 
cause her condition was inexorably deteriorating, an end- 
to-side portacaval anastomosis was performed on March 
1, 1973, in an effort to lower the serum-cholesterol levels. 
The anaesthesia, provided by Dr  Henry Casson, was with 
intravenous diazepam (' Valium '), ketamine (' Ketalar '), 
and pancuronium (' Pavulon ') combined with nitrous 
oxide/oxygen and enflurane (' Ethrane '). Although the 
patient was in severe heart-failure, the procedure was 
well tolerated. 
Open biopsy of the liver was performed immediately 
before portal diversion, and a needle biopsy specimen was 
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Fig. 3-Cbolesterol concentrations before and 6 months dter  
portal diversion. 
The preoperative value represents the mean of 9 determinations 
hone standard deviation. 
taken 168 days later. One portion of each biopsy was 
fixed in 10% neutral formalin and was then processed 
for examination by light microscopy. A second piece of 
tissue was fixed in- buffered glutaraldehyde, post-6xed in 
osmium tetroxide, and then embedded in 'Epon 812 '. 
Sections for elecuon microscopy were stained with lead 
ciuate and examined in a Philips 300 elearon miaoscope. 
The sizes of the midzonal hepatocytes before and after 
portal diversion were '. determined on hzmatoxylin-and- 
eosin stained senions by a method previously desaibed.' 
Midzonal hepatocytes identified in 0.5 p Epon sections 
were also used for measuring the rough endoplasmic 
reticulum length per area of cytoplasm by a morpho- 
metric method.8*' 
R E S U L T S  
On the low-cholesterol/high-polyunsamted-fat 
diet that the patient has received most of her life, 
preoperative fasting serum-cholesterol levels, de- 
tennined by the Lieberrnann-Burchardt colour 
r e a c t i ~ n , ' ~  varied between 720 and 882 mg. per 100 ml., 
with a mean of 769+ 47 (s.D.) mg.'per 100 ml. (fig. 3). 
During the same period in January and February, 
1973, serum-uiglyceride levels (fig. Z), determined by 
the method of Eggstein," varied from 61 to 119 mg. 
per 100 ml. (mean 94 + 18 [s.D.] mg. per 100 mi.). 4 
days after operation her cholesterol value was 615 mg. 
per 100 ml., which was the last level above 600 mg. 
per 100 ml. (fig. 3). The value was 531 mg. per 100 
ml. 1 week after operation and 462 mg. per 100 ml. 
after two weeks. The serum-cholesterol then remained 
between 402 and 454 mg. per 100 ml. until the 4th 
postoperative month, when it fell to 339 mg. per 100 
ml. At the end of a half-year, it had declined to 239 
mg. per 100 ml. (fig. 3). Triglyceride values ranged 
between 43 and % mg. per 100 ml. postoperatively, 
with a mean of 62 i 16 mg. per 100 ml. (fig. 2). Post- 
operatively, both the cholesterol and triglyceride 
levels have been statistically lower than their re- 
spective preoperative levels (~(0-01). 
Low-density-lipoprotein levels, determined by the 
method of Hatch et al.,'? have decreased in parallel 
with the serum-cholesterol. Levels prior to surgery 
were consistently >lo00 mg. per 100 ml., the value 
for the preoperative serum being 1163 mg. per 100 ml. 
The 6-month-postoperative level was 776 mg. per 
100 ml.-still above the upper limits of normal of 579. 
Concurrently with the decline in blood lipoprotein 
and lipid levels has been the remission of cardiac 
symptoms. The patient has had no attacks of the 
previously refractory angina pectoris since the 2nd 
postoperative week and has returned to school and 
full activity. The intensity of the murmur of aortic 
stenosis has decreased. Her heart is still slightly 
enlarged but has decreased postoperatively. The 
skin xanthomas have almost entirely disappeared 
from her lower extremities, and the lesions over the 
remainder of the body are still regressing. There 
have been no adverse sequela, such as hepatic en- 
cephalopathy or hypoglycda,  attributable to the 
ponacaval shunt. She has gained 4.0 kg. in weight 
and 3 cm. in height in the 6 months after operation. 
Lipid-lowering drugs have not been restarted post- 
operatively and she currently receives no medications. 
She is on the same diet as preoperatively, but in due 
time consideration will be given to relaxing this. 
The biopsy specimen obtained before ponacaval 
diversion appeared normal by light microscopy. Ultra- 
structurally, hepato -tes sectioned through a central 
area showed many . omplexes of rough endoplasmic 
reticulum (fig. 4A). Each complex consisted of many 
parallel cisternz of ribosome-studded membranes. 
Free polyribosomes were also present in the cyto- 
plasm: Glycogen was abundant. 
After portacaval diversion the size of the hepato- 
cytes diminished significantly and the amount of fat 
in the cytoplasm of the liver cells increased. Ultra- 
structurally, the amount of rough endoplasmic red- 
culum was greatly reduced; only isolated profiles re- 
mained (figs. 4B and 4C). Morphometric analysis 
showed that the -rea of rough endoplasmic rcti- 
culum per volume ,>i cytoplasm was reduced to about 
one-third the quantity found in the preoperative 
biopsy. The  amount of smooth endoplasmic reti- 
culum was not increased. Free ribosomes were 
relatively abundant. Glycogen particles were rare. 
D I S C U S S I O N  
The diagnosis of homozygous type IIA hyperlipo- 
proteinamia was established in this patient by 
Fredrickson and Levy's major criteria.' First, she 
had the characteristic lipid profile in her plasma with 
an elevated low-density-lipoprotein concentration 
which was twice that of her heterozygotic parents 
and sister. Second, the rype-11 heterozygote pattern 
was demonstrated in the plasma of both her parents. 
In addition, all the minor diagnostic criteria were 
met, including the presence of subcutaneous and 
tendinous lesions before the age of 10 years, the 
appearance of vascular disease before the age of 20 
years, plasma-cholesterol concentrations exceeding 
500 mg. per 100 ml., normal triglyceride level, and no 
evidence of other diseases (hypothyroidism, pan- 
creatitis, &c.) associated with hyperlipidamia. 
The refractoriness of the disorder to conservative 
management was indicated by the failure of a low- 
cholesterol diet or various medications singly or in 
combination to reduce the plasma-cholesterol and 
low-density-lipoprotein concentrations. Cholesryr- 
amine administered in 1967 actually caused an 
increase in serum-cholesterol concentrations, which 
was subsequently noted in two other children with 
type-11 hyperlipoprotein~mia.'~ Despite strict man- 
agement for more than 6 years, the patient's course 
was inexorably downhill, culminating in myocardial 
infarction, intractable heart-failure, and frequent 
attacks of angina pectoris. 
The decision for portacaval shunt under these 
adverse conditions was an outgrowth of an 
earlier proposal to treat hepatic glycogen-storage 
disease by portal diversion." In patients with 
type-I hepatic glycogenosis f' -patic glucose-6- 
phosphatase deficiency) it was bserved that the 
characteristic hyperuiglyceridremia and frequent 
hypercholesterolaxnia of this disorder were com- 
pletely and permanently relieved by ponacaval 
shunt."17 In these type-I glycogen-storage patients, 
the hyperlipidzmia was also partially relieved in 
advance of portacaval shunt by a test period of 
parenteral hyperalimentation.16-l7 The same was true 
in the present case, providing some prior assurance 
of the wisdom of proceeding. The reduction in 
plasma~holesterol concentration following 3 weeks 
of parenteral feeding was the greatest that had been 
achieved with this child during 6 years. After the 
intravenous alimentation was stopped, a return of 
the cholesterol to high levels was delayed for several 
weeks, suggesting that the explanation for the hyper- 
alirnentation effect was more complex than a more 
efficient peripheral utilisation of nuuients delivered 
intravenously. 
The almost immediate fall in the plasma-cholesterol 
after end-to-side portacaval shunt was accompanied 
by a perceptible flattening of some of the skin lesions 
within 10 days. A comparable gradual but hzmo- 
dynamically signific..;lt melting away of xanthomatous 
lesions of the aortic valve and coronary arteries was 
thought to explain the relief of the cardiac symptoms. 
In the ensuing 6 months the skin lesions have re- 
gressed and the aortic systolic murmur has lessened. 
There has been no tendenq for the hyperlipo- 
Fig. rl--Liver-biopsy appearances before (A) and after (B and C) portacaval shunt. 
Rough endoplasmlc renculum (r) and glycogen are abundant in the preoperative biopsy. After portacaval anastomosis only isolated 
protiles of rough endoplasrmc reticulum remam and glycogen is absent. Elecmn micrographs: A, ~ 3 0 1 5 ;  B, ,-: 5575; C, .<25,!3ir. 
proteinzmia to recur. Rather, the plasma-cholesterol 
has slowly declined further from month to month. 
The exact reason for the amelioration of hyperlipo- 
proteinzmia in this patient is not known. The two 
most likely general causes of the disorder are, first, 
overproduction of cholesterol or low-density lipo- 
proteins, or, second, deficient catabolism of these 
substances. In  turn, the effect of portal diversion at 
either a hepatic or extrahepatic site on the production 
or destruction of either cholesterol or low-density 
lipoproteins theoretically could result from: (1) rout- 
ing intestinal nutrients around the liver; (2) bypass- 
ing pancreatic hormones, particularly insulin and 
glucagon; or (3) a combination of (1) and (2). 
Although the relative roles of bypassing intestinal 
nutrients versus the diversion of pancreatic hormones 
in the .wering of serum-cholesterol concentrations 
are nc. ,efinable in our patient, animal experiments 
indicate in a general way that hormonal influences 
upon the liver are more profound than nutritional 
effects.' In these investigations, portions of dog 
livers were differentially exposed to venous blood 
returning from the intestines or alternatively to blood 
returning from the pancreatico/gastroduodeno/splenic 
area. By biochemical studies, the two liver sides were 
demonstrated to have drastically different com- 
positions. Furthermore, the heparic tissue perfused 
with the hormone-rich pancreatic blood soon under- 
went hypertrophy and hyperplasia in contrast to the 
hepatic fragment supplied with nutrient-rich intestinal 
blood. These obse~at ions  prompted the conclusion 
that the hepatotrophic factors in portal venous blood, 
which we have previously stated to be important in 
maintaining hepatic structure and func~on :~  are 
trace quantities of pancreatic hormones, particularly 
insulin and possibly glucagon as well.' 
These experimental findings have made us 
postulate that the remarkable result in our patient 
was due most importantly to elimination of direct 
exposure of the liver to pancreatic hormones 
(especially insulin) and consequent reduction of the 
production phase of cholesterol and low-density 
lipoproteins. This hypothesis was supported by the 
pathological features of marked reduction of rough 
endoplasmic reticulum in our patient's liver biopsy 
53 months after portacaval anastomosis. Studies by 
Jones et al.lS on the synthesis of lipoproteins by the 
liver suggest that both rough and smooth endoplasrnic 
reticulum are involved in this process. I t  will be 
important to elucidate these or other possible 
mechanisms, since with their understanding other 
forms of therapy may be devised. 
In view of the dramatic result in this first case, 
the role of portal diversion in the treatment of hyper- 
lipoproteinsemia will require careful definition. At 
present, portacaval-shunt surgery should be considered 
experimental and restricted to patients like this one 
who are refractory to dietary and medical therapy. 
As a last resort, at least in patients with homozygous 
type-11 disease, portal diversion would seem to be 
simpler, and more permanently beneficial, than the 
ileal bypass procedures of Buchwald and V a r ~ o . ' ~ , ~ , ~ '  
If portal diversion in humans with this kind of meta- 
bolic disorder proves to be tolerated as well as in 
patients with glycogen-storage disease, in whom 
portaprival complications such as hepatic encephalo- 
pathy have not been observed with follow-ups of up 
to a decade," the indications for operative inter- 
vention for hyper l ip idda  may well become broader 
than those limited ones just suggested. Meanwhile, 
an exceptionally careful attitude about case selection 
will be necessary, since the long-term s igdcance  
of the ultrastructural findings in the S t  month biopsy 
are not known. 
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